Chemours CC Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$29M-480% | -$47M-327% | $46M+270% | -$379M-641% | -$5M-109% | ||
| $79M-10.2% | $81M+9.5% | $80M+9.6% | $91M+23.0% | $88M+23.9% | ||
| $7M+40.0% | $4M+33.3% | $5M0.0% | $7M+16.7% | $5M+400% | ||
| -$11M+21.4% | —— | —— | $111M+840% | -$14M— | ||
| $3M0.0% | $2M-33.3% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $1M0.0% | $5M+150% | $16M— | $10M— | $1M— | ||
| —— | —— | $7M— | —— | $1M-66.7% | ||
| -$58M+44.8% | -$86M-196% | —— | —— | -$105M+32.7% | ||
| -$17M+64.6% | $0-100% | -$6M-250% | -$16M+23.8% | -$48M-54.8% | ||
| -$8M-189% | $38M+322% | $3M-76.9% | $230M+3,933% | $9M+280% | ||
| -$14M-138% | —— | $5M— | —— | $37M+436% | ||
| $0— | -$1M-125% | —— | —— | $0-100% | ||
| -$9M— | —— | —— | —— | $0+100% | ||
| $77M-30.6% | -$269M— | -$11M-122% | $63M-37.6% | $111M-40.3% | ||
| $6M-14.3% | —— | $7M-36.4% | $9M0.0% | $7M-36.4% | ||
| -$44M+60.7% | $137M— | $146M— | $93M+115% | -$112M+61.4% | ||
| $49M-41.7% | $45M-58.7% | $41M-46.1% | $43M-41.1% | $84M-17.6% | ||
| $7M— | —— | $6M— | —— | —— | ||
| -$44M+48.8% | -$43M+59.8% | -$35M+53.3% | -$42M+40.0% | -$86M+14.9% | ||
| $13M-64.9% | $15M-58.3% | $13M-65.8% | $13M-64.9% | $37M0.0% | ||
| —— | —— | —— | —— | —— | ||
| $700M— | $653M+331% | —— | —— | —— | ||
| $2M— | —— | —— | —— | $0-100% | ||
| $3M0.0% | $2M-33.3% | $5M+66.7% | $4M+33.3% | $3M0.0% | ||
| $2M+100% | —— | —— | —— | $1M-50.0% | ||
| $10M— | $3M-66.7% | —— | —— | —— | ||
| -$19M+66.7% | -$37M— | -$5M+81.5% | -$27M+32.5% | -$57M-5.6% | ||
| -$2M-133% | $2M+111% | $6M— | $15M+475% | $6M+167% | ||
| -$109M+56.2% | —— | —— | —— | -$249M+45.2% | ||
| —— | $62.75M-6.0% | $62.75M-6.0% | $62.75M-6.0% | $62.75M-6.0% | ||
| —— | $18.5M-9.8% | $18.5M-9.8% | $18.5M-9.8% | $18.5M-9.8% | ||
| $3M0.0% | $2M-33.3% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $1M-75.0% | —— | —— | $4M+33.3% | $4M0.0% | ||
| —— | —— | $7M— | —— | $1M-66.7% | ||
| $6M-14.3% | —— | $7M-36.4% | $9M0.0% | $7M-36.4% | ||
| $77M-30.6% | -$269M— | -$11M-122% | $63M-37.6% | $111M-40.3% | ||
| -$32M-163% | $30M-40.0% | $34M-58.0% | $0— | $51M+75.9% | ||
| $12M+340% | -$95M-164% | $22M— | $75M+112% | -$5M+89.1% | ||
| -$8M-189% | $38M+322% | $3M-76.9% | $230M+3,933% | $9M+280% | ||
| $1M0.0% | $5M+150% | $16M— | $10M— | $1M— | ||
| $3M+50.0% | —— | $1M+200% | —— | $2M0.0% | ||
| $1M— | —— | —— | —— | —— | ||
| $7M— | —— | $6M— | —— | —— | ||
| $3M0.0% | $2M-33.3% | $5M+66.7% | $4M+33.3% | $3M0.0% | ||
| $6M— | —— | —— | —— | —— | ||
| $10M— | $3M-66.7% | —— | —— | —— | ||
| $14M-60.0% | $18M-18.2% | $17M-10.5% | $18M-25.0% | $35M-5.4% | ||
| $700M— | $653M+331% | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $16M-40.7% | $16M-38.5% | $17M-15.0% | $20M0.0% | $27M0.0% | ||
| $689M+8,513% | $668M+40.0% | $8M0.0% | $103M+5,050% | $8M+167% | ||
| —— | $18.5M-9.8% | $18.5M-9.8% | $18.5M-9.8% | $18.5M-9.8% | ||
| -$93M+52.6% | $92M— | —— | —— | -$196M+50.0% | ||
| -$93M+52.6% | $92M— | —— | —— | -$196M+50.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Chemours generate?
- Chemours (CC) generated $332.0M in operating cash flow over the trailing twelve months.
- What is Chemours's free cash flow?
- After $178.0M of capital expenditures, Chemours's free cash flow was -$890.0M over the trailing twelve months, down 436.1% year over year.
- Where does Chemours's cash flow data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
